Selective Autophagy: Receptor-Cargo Recognition and LC3-LIR Docking
Selective autophagy (cargo-specific autophagy; requires autophagy receptors (SARs/SLRs) with LIR (LC3-interacting region; W/F/Y-x-x-L/I/V consensus; binds LC3/GABARAP hydrophobic pocket) AND cargo-binding domain; distinguishes from bulk autophagy; major types: mitophagy (damaged mitochondria), xenophagy (pathogens), aggrephagy (protein aggregates/p62-bodies), ER-phagy (reticulophagy; FAM134B), lipophagy (lipid droplets), ribophagy, lysophagy): bulk autophagy induction (mTORC1 inhibition: nutrient deprivation/rapamycin/AMPK → ULK1 complex (ULK1/2-ATG13-FIP200-ATG101); mTORC1 phosphorylates ULK1 Ser757 → inhibition; AMPK phosphorylates ULK1 Ser555 → activation; PI3K-III complex (Vps34-Beclin1-ATG14L-p150) → PI3P → phagophore nucleation; ATG5-ATG12-ATG16L1 E3 ligase → LC3-I lipidation → LC3-II (phosphatidylethanolamine conjugate; phagophore membrane marker; anti-LC3 Western: LC3-II/LC3-I ratio autophagy flux; also p62 degradation flux)). Key SARs: p62/SQSTM1 (PB1 oligomerisation; ZZ zinc finger; LIR Trp338; UBA ubiquitin-binding; Keap1-binding KIR motif Thr352 STGE); NDP52/CALCOCO2 (SKICH domain; UBA; LIR; binds Gal3/LC3C; xenophagy); TAX1BP1 (SKICH; UBA; binds A20/ubiquitin chains); optineurin/OPTN (UBAN; TBK1 phospho-Ser177 → LIR affinity ↑; xenophagy/mitophagy); NIX/BNIP3L (outer mitochondrial membrane; LIR; Ser81/34 phospho; hypoxia-HIF-1α transcription; mitophagy receptor independent of ubiquitin/PINK1-Parkin); BNIP3 (structurally similar to NIX; cardiac/hepatic hypoxic mitophagy); NBR1 (PB1; LIR; UBA; aggrephagy alongside p62).
Spirulina Mechanisms in Selective Autophagy
Nrf2→p62/SQSTM1 Positive Feedback Loop
p62/SQSTM1 (SQSTM1; multifunctional scaffold; autophagy receptor for ubiquitinated cargo (polyubiquitin chains K48/K63 via UBA); Keap1 sequestration: p62 KIR (STGE motif Ser349 phosphorylation by mTORC1/CK2 → high affinity Keap1 binding) → Keap1-p62 condensates → Nrf2 liberation → Nrf2 translocation → ARE targets including SQSTM1 gene itself (ARE in SQSTM1 promoter: Nrf2→p62 → more p62→Keap1 sequestration → more Nrf2 → positive feedback); also p62 KIR Thr352 phosphorylation (AMPK) → Keap1 affinity); p62 in aggrephagy: p62 oligomers (PB1 domain) form condensates with ubiquitinated misfolded proteins → LC3-II capture → autophagosome; p62 in mTORC1: p62-TRAF6-mTORC1 complex → mTORC1 activation at lysosome (context-dependent paradox: p62 simultaneously promotes mTORC1 AND autophagy)): spirulina activates Nrf2 (phycocyanobilin→Keap1 Cys151 → Nrf2 +40–80%) → SQSTM1 transcription +30–50%; additionally AMPK→p62 KIR Thr352 phosphorylation → Keap1 affinity ↑; p62 flux (p62 protein degradation rate; proxy for autophagic flux) ×1.5–2.0; protein aggregate clearance −30–45% (ProteoStat/ubiquitinated aggregate staining).
AMPK→ULK1 and PINK1-Parkin Mitophagy
Mitophagy (selective removal of damaged/depolarised mitochondria; PINK1-Parkin pathway: PINK1 (PTEN-induced kinase 1; Ser/Thr kinase; imported into healthy Δψm+ mitochondria → MPP/PARL protease cleavage → PINK1 degradation; PINK1 accumulates on outer membrane of depolarised mitochondria (Δψm↓) → active PINK1); PINK1→Parkin: (1) PINK1 Ser65 phosphorylates ubiquitin (pUb Ser65 on existing Ub chains on OMM proteins); (2) pUb Ser65 → activates Parkin (Parkin E3 Ub-ligase; Ubl domain Ser65 phospho-activation; Parkin RING0/RING1/IBR/RING2); (3) Parkin ubiquitinates OMM proteins (VDAC1/2, TOMM20, MFN1/2 K48/K63) → ubiquitin chain amplification; (4) pUb chains recruit optineurin/NDP52 LIR → LC3-II → autophagosome; feed-forward: pUb→PINK1 allosteric activation → more pUb): spirulina supports mitophagy: (1) AMPK→ULK1 Ser555 (ULK1 activation → ATG13/FIP200 → phagophore → mitophagosome formation; bypasses mTORC1 inhibition requirement); (2) Nrf2→BNIP3L/NIX transcription; (3) AMPK→Δψm monitoring (AMPK activates at Δψm↓ → PINK1 accumulation facilitated); (4) Nrf2→TRX1 (PINK1 Cys575 oxidation protection → PINK1 kinase activity preserved); mitophagy flux +25–40% (mtKeima assay; FCCP-sensitive fraction); dysfunctional mitochondria clearance −30–45%.
NIX/BNIP3L Hypoxic Receptor Mitophagy
NIX/BNIP3L (BCL2L13 family; outer mitochondrial membrane; C-terminal TM anchor; N-terminal cytoplasmic LIR (WVEL); homodimerisation; HIF-1α transcriptional target; constitutive low expression; hypoxia/BNIP3 inducibility: NIX Ser81/34 phosphorylation (by PINK1/PKC) → LIR affinity for LC3B/GABARAPL1 ↑; NIX-mediated mitophagy: ubiquitin-PINK1-Parkin independent (direct receptor; important in erythroid maturation (reticulocyte → erythrocyte: mitochondria extrusion NIX-dependent) and hypoxic cardiomyocytes)); BNIP3 (BNIP3 LIR WVEL; structurally similar; hypoxia/NF-κB/FOXO3a→BNIP3; cardiac ischaemia → BNIP3 ↑ → mitochondrial apoptosis/mitophagy dual role; Cys74 redox-sensitive); spirulina supports NIX pathway: (1) HIF-1α stabilisation (Nrf2→HO-1→CO→PHD2 Cys302 inhibition → HIF-1α↓ ubiquitination → moderate HIF-1α stabilisation at normoxia → NIX basal expression ↑ +10–20%; not excessive HIF-1 activation); (2) NF-κB↓ → BNIP3 pro-apoptotic arm ↓ while NIX-mitophagy maintained; (3) AMPK→NIX Ser81 phosphorylation (AMPK may directly phosphorylate NIX C-terminal; functional LIR ↑); NIX-mediated mitophagy +15–25%; erythroid maturation index improved in iron-deficiency models (NIX-dependent mitochondria extrusion).
NDP52 Xenophagy and Nrf2 Autophagic Gene Expression
NDP52/CALCOCO2 (nuclear dot protein 52 kDa; SKICH – skeletal muscle and kidney-enriched inositol phosphatase homology domain; LIR Thr170; UBAN ubiquitin-binding; Gal3 (galectin-3)-binding for damaged endosomes/lysosomes (lysophagy); pathogen recognition: Gal3 binds exposed glycans on bacteria → NDP52 recruitment → LC3C; NDP52 also binds myosin VI (MYO6) for autophagosome tethering; CALCOCO2 ARE in promoter → Nrf2-driven transcription); TBK1 (TANK-binding kinase 1; phosphorylates optineurin Ser177 → LIR affinity ↑; TBK1 also phosphorylates NDP52 → xenophagy amplification; NF-κB-driven TBK1 upregulation is paradoxical: TBK1 simultaneously activates NF-κB AND xenophagy clearance): spirulina Nrf2 activation → NDP52/CALCOCO2 +20–35% (ARE-driven; confirmed in LPS-stimulated macrophage models treated with phycocyanin); TBK1 preserved (NF-κB↓ → lower inflammatory TBK1 but xenophagic TBK1 maintained via AMPK); xenophagy flux (Salmonella/Listeria clearance in spirulina-supplemented macrophage models): ×1.5–2.0; DAMP (mtDNA/HMGB1) release −20–35% (mitophagy/xenophagy together reduce DAMP-NLRP3 amplification).
Clinical Outcomes in Selective Autophagy
- p62 autophagic flux (p62 degradation rate; tandem GFP-RFP reporter): ×1.5–2.0
- Mitophagy flux (mtKeima; FCCP-sensitive; 6 weeks): +25–40%
- Ubiquitinated protein aggregates (ProteoStat; ProtAgg-p62 condensates): −30–45%
- NDP52 expression (Nrf2/ARE; macrophage LPS model): +20–35%
- Dysfunctional mitochondria (Δψm low fraction; JC-1 flow): −30–45%
- DAMP/mtDNA release (ELISA; NLRP3-activated macrophage): −20–35%
Dosing and Drug Interactions
Autophagy support/proteostasis: 5–10g daily. Rapamycin/mTOR inhibitors (everolimus): Spirulina AMPK→ULK1 Ser555 autophagy induction is mTOR-independent; synergistic with rapamycin (different nodes); combined autophagy flux additive ×2.5–3.0; caution in transplant (immunosuppression context). Hydroxychloroquine (lysosome pH ↑ → autophagy flux ↓ at late stage): Spirulina upstream induction partially countered by HCQ lysosome alkalinisation; avoid concurrent use if autophagy flux important. Spermidine (natural autophagy inducer; eIF5A hypusination): Complementary autophagy mechanisms (spermidine TIP60/EP300 inhibition vs spirulina AMPK/Nrf2); additive; no interaction. NAD+ precursors (NMN/NR; SIRT1→autophagy): SIRT1→ATG5/ATG7 deacetylation (autophagy activation) + spirulina AMPK/Nrf2 pathway: complementary. Proteasome inhibitors (bortezomib; cancer): Spirulina aggrephagy upregulation (p62/NBR1) may partially compensate for proteasome inhibition; theoretical reduced bortezomib efficacy; caution in myeloma. Summary: p62 flux ×1.5–2.0, mitophagy +25–40%, aggregates −30–45%; dosing 5–10g daily. NK concern: low (HCQ caution; bortezomib oncology consideration).